EEF1A1P3: A Drug Target / Disease Biomarker (G100421865)

Target Name: EEF1A1P3

NCBI ID: G100421865

EEF1A1P3

Other Name(s): EEF1AL1 | Eukaryotic translation elongation factor 1 alpha 1 pseudogene 3 | eukaryotic translation elongation factor 1 alpha 1 pseudogene 3 | EEF1AL

EEF1A1P3: A Drug Target / Disease Biomarker

EEF1A1P3 is a protein that is expressed in various tissues throughout the body. It is a key regulator of the development and maintenance of tissues, including the epithelial tissue. This protein has been identified as a potential drug target or biomarker due to its involvement in various diseases, including cancer, fibrosis, and regenerative diseases.

One of the key functions of EEF1A1P3 is its role in cell signaling. This protein is involved in the FGF signaling pathway, which is a well-established pathway for the regulation of cell growth, differentiation, and survival. The FGF signaling pathway is involved in the development and maintenance of tissues, including the epithelial tissue, which is responsible for maintaining the integrity of the body's barriers, such as the skin and the lining of the various body systems.

EEF1A1P3 is a key regulator of the FGF signaling pathway in epithelial cells. It is involved in the regulation of cell proliferation, differentiation, and survival. This is accomplished through its interaction with the FGF receptor, which is a transmembrane protein that is involved in the regulation of cell growth and survival.

EEF1A1P3 is also involved in the regulation of the FGF signaling pathway in other cell types. For example, it is has been shown to be involved in the regulation of cell proliferation and differentiation in various tissues, including the liver, pancreas, and skin.

In addition to its role in cell signaling, EEF1A1P3 is also considered a potential drug target or biomarker due to its involvement in various diseases. For example, it has been shown to be involved in the development and progression of various cancers, including breast, ovarian, and colorectal cancers. It is also involved in the regulation of fibrosis, which is the excessive growth and development of connective tissue, which can lead to the development of a variety of diseases, including heart disease, diabetes, and cancer.

EEF1A1P3 is also involved in the regulation of regenerative diseases, such as tissue engineering and transplantation. This is accomplished through its role in the regulation of cell proliferation and differentiation, as well as its ability to promote the formation of tissues and organs.

In conclusion, EEF1A1P3 is a protein that is involved in the regulation of various cellular processes that are important for the development and maintenance of tissues. Its involvement in the FGF signaling pathway, as well as its potential involvement in the regulation of cancer, fibrosis, and regenerative diseases, makes it an attractive target for research and development as a drug or biomarker.

Protein Name: Eukaryotic Translation Elongation Factor 1 Alpha 1 Pseudogene 3

The "EEF1A1P3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EEF1A1P3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets